Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This study will determine the efficacy of oral risperidone (Risperdal) versus long-acting injectable paliperidone palmitate (Invega Sustenna) in treating people with first-episode schizophrenia.
Epistemonikos ID: 1f3a6891fdc41d02c1e21e823cc9c6b4d3c8580b
First added on: May 10, 2024